logo

CIPLA vs HDFCLIFE: Stock Comparison

CIPLA vs HDFC LIFE INS COUpdated 23 Oct 26, 4:08 PM ISTNSE & company filings

HDFC LIFE INS CO is the larger company by market capitalisation. CIPLA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CIPLA leads 8; HDFCLIFE leads 1 of 9

Not a rating
These companies operate in different sectors (Healthcare vs Financial Services). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CIPLAHDFCLIFE

Valuation lens

What price are you paying?

Market CapContext only
₹1.08 L Cr
₹1.14 L Cr
P/E RatioCIPLA has the lower reading
32.04x ✓
55.34x
P/B RatioCIPLA has the lower reading
3.14x ✓
5.8x
EPSCIPLA has the higher reading
₹9.77 ✓
₹2.4
Book ValueContext only
₹427.31
₹81.7
Dividend YieldCIPLA has the higher reading
0.97% ✓
0.4%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
HDFCLIFE is the larger company
₹1.14 L Cr vs ₹1.08 L Cr
P/E Ratio
CIPLA has a lower P/E
32.04x vs 55.34x
P/B Ratio
CIPLA has a lower P/B
3.14x vs 5.8x
EPS
CIPLA has higher earnings per share
₹9.77 vs ₹2.4
Dividend Yield
CIPLA has a higher dividend yield
0.97% vs 0.4%
Revenue Growth (TTM YoY)
CIPLA has faster revenue growth
-2.1% vs -17.7%
EPS Growth (TTM YoY)
HDFCLIFE has faster EPS growth
4.1% vs -54.6%
ROE
CIPLA has a higher ROE
11.19% vs 10.79%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCIPLAHDFCLIFE
SectorHealthcareFinancial Services
IndustryPharmaceuticalsLife Insurance

Price

MetricCIPLAHDFCLIFE
Live Price₹1,338₹523.75
Day Change0.53%-0.87%
Volume13.24 L14.34 L
52-Week High₹1,673₹788.5
52-Week Low₹1,165.7₹508.7
Distance from 52W High-20.02%-33.58%

Valuation

MetricCIPLAHDFCLIFE
Market Cap₹1.08 L Cr₹1.14 L Cr
P/E Ratio32.04x55.34x
P/B Ratio3.14x5.8x
EPS₹9.77₹2.4
Book Value₹427.31₹81.7
Dividend Yield0.97%0.4%

Growth

MetricCIPLAHDFCLIFE
Revenue Growth (TTM YoY)-2.1%-17.7%
EPS Growth (TTM YoY)-54.6%4.1%
Qtr Sales Growth8.84%—
Qtr Profit Growth44.8%—

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricCIPLAHDFCLIFE
ROE11.19%10.79%
ROCE11.58%—
Net Margin13.96%1.89%
Operating Margin18.74%1.99%
Debt to Equity0.01x0.18x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCIPLAHDFCLIFE
Promoter Holding9.17%50.54%▲ 0.33 pp
FII Holding20.21%▼ 2.35 pp19.27%▼ 3.25 pp
DII Holding34.63%▲ 2.66 pp20.19%▲ 2.94 pp
Public Holding15.94%▼ 0.31 pp9.98%▼ 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CIPLA and HDFC LIFE INS CO.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.